News
03-30-2011, 05:10 AM
BioSante Pharmaceuticals, Inc. today announced that enrollment of subjects in the second of two pivotal Phase III LibiGel safety and efficacy trials has been completed. Enrollment in the first LibiGel efficacy trial was completed in February.
More... (http://www.news-medical.net/news/20110330/BioSante-completes-patient-enrollment-in-LibiGel-Phase-III-trial-against-HSDD.aspx)
More... (http://www.news-medical.net/news/20110330/BioSante-completes-patient-enrollment-in-LibiGel-Phase-III-trial-against-HSDD.aspx)